This is a working overview of LC-MS/MS, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-01-07. Anything still debated is marked as such rather than presented as settled.
SR9009 is often grouped with compounds studied for circadian and metabolic regulation rather than with classical anabolic steroids. Its interactions with nuclear receptors differ from those of androgen receptor ligands, and its proposed mechanisms involve transcriptional control rather than direct hormone signaling. Some sources classify it as a metabolic modulator because of observed effects on energy utilization. The distinction matters for regulation and for interpreting research results across different compound classes.
SR9009 is a synthetic small molecule developed as a REV-ERB agonist. It binds to REV-ERBα and REV-ERBβ, nuclear receptors that help regulate circadian rhythms and metabolic gene expression. In cell and animal studies, the compound alters lipid and glucose handling and influences skeletal muscle oxidative capacity. Its exact effects in humans remain largely uncharacterized because controlled clinical trials have not been reported. The molecule is frequently described in preclinical literature as a metabolic modulator.
Research interest in SR9009 grew from studies showing improved running endurance in mice after short treatment periods. Those experiments linked the compound to increased mitochondrial content and fatty acid oxidation in muscle, but the findings come from animal models and specific dosing schedules. Independent replication has been limited, and the pathways connecting REV-ERB activation to exercise performance are still being mapped. Whether similar responses occur in humans is an open question.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C20H24ClN3O4S | Reported for the free base |
| Molecular weight | 437.9 g/mol | Calculated from the formula |
| Primary target | REV-ERBα and REV-ERBβ | Nuclear receptors involved in circadian regulation |
| Solubility | Soluble in DMSO and ethanol | Poorly soluble in water |
| Typical storage | -20 °C, desiccated | Protect from light and moisture |
In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.
Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.
Detection of SR9009 in biological samples usually relies on liquid chromatography coupled to tandem mass spectrometry. This approach separates the compound from matrix components and identifies it by mass transitions. Because SR9009 can undergo metabolism, laboratories often look for both parent drug and specific metabolites. Sample preparation may involve protein precipitation or solid-phase extraction. Method validation examines sensitivity, carryover, and interference from related substances, and reference standards are required for accurate calibration.
Storage recommendations for SR9009 reference material typically specify a freezer at -20 °C or lower, with protection from moisture and light. Repeated freeze-thaw cycles can degrade small molecules and introduce variability. Stock solutions in dimethyl sulfoxide are often aliquoted to avoid repeated handling. Stability studies may examine degradation under heat, humidity, and light exposure. The compound's thiophene and nitro groups can participate in reactions that alter analytical signals over time, so such changes affect quantitative results.
== Mechanisms of pathogenicity == The mechanisms of P. syringae pathogenicity can be separated into several categories: ability to invade a plant, ability to overcome host resistance, biofilm formation, and production of proteins with ice-nucleating properties.
In April 2019, Collins began filming for her own reality series, Gemma Collins: Diva Forever. The series premiered in August 2019 on ITVBe. The pilot episode premiered to a total of 673,038 viewers, and was the most watched episode on ITVBe in that week. The same month, Collins began hosting a podcast on BBC Sounds, titled The Gemma Collins Podcast. It was also reported that Collins had signed a record deal with Universal Music Group, and was set to release a single with Naughty Boy after the pair met at the BRIT Awards 2019 and had been impressed by Collins' vocal ability, however plans for this never materialised. Diva Forever was subsequently renewed by ITV for a second series, but due to the COVID-19 pandemic, production was suspended. As a result, Collins filmed a new reality series, Gemma Collins: Diva on Lockdown, which featured Collins and her family in lockdown and aired between April and May 2020. In August 2020, Collins began hosting a second podcast on BBC Sounds entitled The Gemma Collins Love Lounge. In October 2020, Gemma Collins: Diva Forever & Ever premiered on ITVBe. In December 2020, Collins released a charity single, a cover of "Baby, It's Cold Outside" alongside her Celebrity Big Brother co-star Darren Day, with proceeds from the single going towards Rethink Mental Illness. The music video was released at the end of Gemma Collins: Diva for Xmas, which aired two days prior to the single's release and transpired to be the final episode of the show.
=== Music === Musician Hayley Williams wrote and released a song titled Mirtazapine describing her positive experience with the medication. In 2025 it was released on Ego Death at a Bachelorette Party, her third solo album.
==== Domestic research and experimentation tax deduction ==== The law allows full expensing of domestic research and experimentation expenditures for tax years beginning on or after January 1, 2025. The law allows businesses to hold an election to amortize domestic research and experimentation expenditures that are otherwise capitalized (other than property that would be depreciated or depleted) over a five-year period. The law allows certain businesses to elect to claim a tax deduction for unamortized domestic research and experimentation costs in the first tax year beginning after 2024 or ratably over a two-year period. The law allows certain small businesses to retroactively expense its domestic research and experimentation costs for tax years that began on or after January 1, 2022.
=== Extremism and hate === Concerns have been voiced regarding content relating to, and the promotion and spreading of, hate speech and far-right extremism, such as antisemitism, islamophobia, racism, and xenophobia. Some videos were shown to expressly promote Holocaust denial and told viewers to take up arms and fight in the name of white supremacy and the swastika. As TikTok has gained popularity among young children, and the popularity of extremist and hateful content is growing, calls for tighter restrictions on their flexible boundaries have been made. TikTok has since released tougher parental controls to filter out inappropriate content and to ensure they can provide sufficient protection and security. In October 2019, TikTok removed about two dozen accounts that were responsible for posting ISIL propaganda and execution videos on the app. In Malaysia, TikTok is used by some users to engage in hate speech against race and religion especially mentioning the 13 May incident after the 2022 election. TikTok responded by taking down videos with content that violated their community guidelines. In March 2023, The Jewish Chronicle reported that TikTok still hosted videos that promoted the neo-Nazi propaganda film Europa: The Last Battle, despite having been alerted to the issue four months prior. TikTok said it removed and would continue to remove the content and associated accounts and has blocked the search term as well.
Sources: en.wikipedia.org
==== Symptoms ==== An intoxication in man with hexobarbital can result in sluggishness, incoordination, difficulty in thinking, slowness of speech, faulty judgment, drowsiness or coma, shallow breathing and staggering. In some severe cases coma and death can be the result of an overdose.
Meanwhile, Prime Minister Mirtha Vásquez gave a statement, saying that the government respects an attitude of non-interference in the Armed Forces. She stated that "serious" facts were revealed, and that a decision would be announced within the next few hours. On 13 November 2021, Justice Minister Aníbal Torres called on Walter Ayala to resign. Meanwhile, Health Minister Hernando Cevallos stated that Castillo was very annoyed with presidential secretary Bruno Pacheco's behavior, and that he had removed those people who may violate the independence of the armed forces. Additionally, rumors grew that Prime Minister Mirtha Vásquez might resign due to the controversy. In Peruvian law, the resignation of the PM dissolves the entire cabinet. Responding to the rumors, Labor Minister Betssy Chávez said that there was "a lot of speculation" on the matter, but affirmed that the cabinet would work together. Meanwhile, Aníbal Torres downplayed such rumors, saying that he hadn't seen "differences" between Castillo and Vásquez. On 14 November 2021, Walter Ayala announced his irrevocable resignation. However, the next day, Ayala stated that the resignation would only become effective once Castillo accepted it, and that he would continue working in the meanwhile. Ayala stated that he could not abandon his post since there was no replacement as of then, and accused Congress of not allowing him to work. Later that day, Castillo accepted the resignation of Walter Ayala and thanked him for his services. On 17 November 2021, Juan Carrasco was sworn in as the new Defense Minister.
Using 3-nitrotriazol-5-one (NTO), or 1,3,5-triamino-2,4,6-trinitrobenzene (TATB) (available in two particle sizes (5 μm, 40 μm)), as a substitute for RDX, is also able to improve stability to thermal, shock, and impact/friction stimulus; however, TATB is not cost-effective, and NTO is more difficult to use in the manufacturing process.
=== Psychiatric disorders === Cyproheptadine was studied in one small trial as an adjunct in people with schizophrenia whose condition was stable and were on other medication; while attention and verbal fluency appeared to be improved, the study was too small to draw generalizations from. It has also been studied as an adjuvant in two other trials in people with schizophrenia, around fifty people overall, and did not appear to have an effect. Cyproheptadine has been studied for the treatment of post-traumatic stress disorder.
Sources: en.wikipedia.org
It is a synthetic REV-ERB agonist used mainly in preclinical research. It is not an approved medicine for human use.
It binds to REV-ERBα and REV-ERBβ, nuclear receptors involved in circadian and metabolic gene regulation. This can alter transcription of genes related to lipid and glucose metabolism in experimental models.
No controlled human trials have established that effect. Endurance findings come primarily from rodent studies, and human responses remain unknown.
It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.